Article
Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer.
Human genomics - 26 Mar 2025
Wang Qi-Wen, Zou Wen-Bin, Masson Emmanuelle, Férec Claude, Liao Zhuan, Chen Jian-Min
Abstract excerpt
Serine peptidase inhibitor, Kazal type 1 (SPINK1), a 56-amino-acid protein in its mature form, was among the first pancreatic enzymes to be extensively characterized biochemically and functionally. Synthesized primarily in pancreatic acinar cells and traditionally known as pancreatic secretory trypsin inhibitor, SPINK1 protects the pancreas by inhibiting prematurely activated trypsin. Since 2000, interest in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
